Iradimed Share Price (NASDAQ: IRMD)

$72.66

▲

2.13

(3.02%)

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Iradimed Stock chart to analyse performance

Iradimed stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$72.41
Today's High:$72.96
$72.66
0.34%
Downside
Day's Volatility :0.75%
Upside
0.41%
52 Weeks Low:$44.58
52 Weeks High:$73.47
$72.66
38.65%
Downside
52 Weeks Volatility :39.32%
Upside
1.1%

Iradimed Stock Returns

Period	Iradimed Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	38.63%	6.0%	0.0%
6 Months	32.12%	-5.6%	0.0%
1 Year	55.26%	-11.1%	0.0%
3 Years	107.67%	6.8%	-7.8%

Iradimed Corp Key Stats

Check Iradimed key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$70.53
Open	$72.96
Today's High	$72.96
Today's Low	$72.41
Market Capitalization	$897.1M
Today's Volume	$86.8K
52 Week High	$73.47
52 Week Low	$44.58
Revenue TTM	$77.6M
EBITDA	$24.6M
Earnings Per Share (EPS)	$1.61
PE Ratio	43.81
Dividend Yield	0.95%
Profit Margin	26.61%
Quarterly Earnings Growth YOY	0.18%
Return On Equity TTM	23.75%

Stock Returns calculator for Iradimed Stock including INR - Dollar returns

The Iradimed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Iradimed investment value today

Current value as on today

₹1,59,175

Returns

₹59,175

(+59.18%)

Returns from Iradimed Stock

₹54,859 (+54.86%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Iradimed Stock

167%

Period: Jul 24, 2025 to Aug 23, 2025. Change in 30 Days versus previous period

Search interest for Iradimed Stock from India on INDmoney has increased by 167% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Iradimed Corp

Name
Holdings %
Name
Holdings %
BlackRock Inc
7.44%
Nine Ten Capital Management LLC
6.86%
Vanguard Group Inc
4.41%
Renaissance Technologies Corp
3.94%
Copeland Capital Management, LLC
3.60%
Geode Capital Management, LLC
1.93%

Analyst Recommendation on Iradimed Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Iradimed(by analysts ranked 0 to 5 stars)

Iradimed Share Price Target

What analysts predicted

Upside of 1.16%

Target:

$73.50

Current:

$72.66

Iradimed share price target is $73.50, a slight Upside of 1.16% compared to current price of $72.66 as per analysts' prediction.

Iradimed Stock Insights

Price Movement
In the last 1 month, IRMD stock has moved up by 27.8%
Increasing Revenue
Revenue is up for the last 21 quarters, 6.79M → 20.40M (in $), with an average increase of 5.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 4.68M → 5.77M (in $), with an average increase of 18.8% per quarter
IRMD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 159.8% return, outperforming this stock by 55.6%

Iradimed Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$38.5M	↑ 26.54%
Net Income	$9.6M	↑ 52.79%
Net Profit Margin	25.0%	↑ 4.29%

	FY20	Y/Y Change
Revenue	$31.7M	↓ 17.65%
Net Income	$1.4M	↓ 85.79%
Net Profit Margin	4.32%	↓ 20.68%

	FY21	Y/Y Change
Revenue	$41.8M	↑ 31.83%
Net Income	$9.3M	↑ 581.19%
Net Profit Margin	22.3%	↑ 17.98%

	FY22	Y/Y Change
Revenue	$53.3M	↑ 27.48%
Net Income	$12.8M	↑ 37.55%
Net Profit Margin	24.06%	↑ 1.76%

	FY23	Y/Y Change
Revenue	$65.6M	↑ 23.0%
Net Income	$17.2M	↑ 34.03%
Net Profit Margin	26.22%	↑ 2.16%

	FY24	Y/Y Change
Revenue	$73.2M	↑ 11.71%
Net Income	$19.2M	↑ 11.87%
Net Profit Margin	26.26%	↑ 0.04%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$17.6M	↑ 0.84%
Net Income	$4.1M	↓ 8.88%
Net Profit Margin	23.51%	↓ 2.5%

	Q2 FY24	Q/Q Change
Revenue	$17.9M	↑ 1.88%
Net Income	$4.9M	↑ 18.49%
Net Profit Margin	27.34%	↑ 3.83%

	Q3 FY24	Q/Q Change
Revenue	$18.3M	↑ 2.21%
Net Income	$5.0M	↑ 3.03%
Net Profit Margin	27.55%	↑ 0.21%

	Q4 FY24	Q/Q Change
Revenue	$19.4M	↑ 5.8%
Net Income	$5.1M	↑ 1.93%
Net Profit Margin	26.54%	↓ 1.01%

	Q1 FY25	Q/Q Change
Revenue	$19.5M	↑ 0.63%
Net Income	$4.7M	↓ 8.92%
Net Profit Margin	24.02%	↓ 2.52%

	Q2 FY25	Q/Q Change
Revenue	$20.4M	↑ 4.61%
Net Income	$5.8M	↑ 23.18%
Net Profit Margin	28.29%	↑ 4.27%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$29.7M	↑ 27.87%

	FY20	Y/Y Change
Profit	$23.6M	↓ 20.63%

	FY21	Y/Y Change
Profit	$32.0M	↑ 35.95%

	FY22	Y/Y Change
Profit	$41.3M	↑ 28.81%

	FY23	Y/Y Change
Profit	$50.2M	↑ 21.5%

	FY24	Y/Y Change
Profit	$56.3M	↑ 12.34%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$13.4M	↓ 0.19%

	Q2 FY24	Q/Q Change
Profit	$14.0M	↑ 4.65%

	Q3 FY24	Q/Q Change
Profit	$14.2M	↑ 1.3%

	Q4 FY24	Q/Q Change
Profit	$14.8M	↑ 4.01%

	Q1 FY25	Q/Q Change
Profit	$14.8M	↑ 0.56%

	Q2 FY25	Q/Q Change
Profit	$16.0M	↑ 7.49%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$10.2M	↑ 38.73%
Investing Cash Flow	$3.2M	↑ 111.18%
Financing Cash Flow	$2.0M	↑ 117.25%

	FY20	Y/Y Change
Operating Cash Flow	$5.8M	↓ 43.15%
Investing Cash Flow	$247.0K	↓ 92.29%
Financing Cash Flow	$522.5K	↓ 74.14%

	FY21	Y/Y Change
Operating Cash Flow	$11.3M	↑ 93.52%
Investing Cash Flow	$648.2K	↑ 162.48%
Financing Cash Flow	$24.4K	↓ 95.33%

	FY22	Y/Y Change
Operating Cash Flow	$10.0M	↓ 10.8%
Investing Cash Flow	$-1.4M	↓ 312.11%
Financing Cash Flow	$-12.7M	↓ 52122.11%

	FY23	Y/Y Change
Operating Cash Flow	$13.5M	↑ 34.08%
Investing Cash Flow	$-8.0M	↑ 482.34%
Financing Cash Flow	$-13.7M	↑ 7.48%

	FY24	Y/Y Change
Operating Cash Flow	$25.6M	↑ 90.3%
Investing Cash Flow	$-8.8M	↑ 10.11%
Financing Cash Flow	$-14.3M	↑ 4.98%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$3.9M	↓ 0.75%
Investing Cash Flow	$-478.8K	↓ 24.34%
Financing Cash Flow	$-8.0M	↑ 2961.76%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$6.6M	↑ 70.96%
Investing Cash Flow	$-1.3M	↑ 165.2%
Financing Cash Flow	$-2.0M	↓ 75.62%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$9.1M	↑ 37.32%
Investing Cash Flow	$-4.0M	↑ 215.92%
Financing Cash Flow	$-1.9M	↓ 2.14%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$6.0M	↓ 34.32%
Investing Cash Flow	$-3.1M	↓ 23.8%
Financing Cash Flow	$-2.4M	↑ 26.02%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$4.3M	↓ 28.31%
Investing Cash Flow	$-3.9M	↑ 28.15%
Financing Cash Flow	$-2.3M	↓ 5.78%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$7.7M	↑ 80.48%
Investing Cash Flow	$-2.8M	↓ 27.92%
Financing Cash Flow	$-2.3M	↓ 0.89%

Iradimed Technicals Summary

Sell

Neutral

Buy

Iradimed is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Iradimed Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iradimed Corp	28.71%	32.12%	55.26%	107.67%	234.02%
Medtronic Plc	-0.24%	2.83%	3.78%	0.63%	-9.62%
Edwards Lifesciences Corp.	2.2%	12.37%	18.92%	-15.41%	1.75%
Boston Scientific Corp.	0.01%	1.69%	33.57%	154.07%	167.79%
Stryker Corporation	-2.33%	1.6%	11.24%	81.88%	107.9%
Abbott Laboratories	4.76%	-1.77%	17.62%	25.19%	29.36%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iradimed Corp	43.81	43.81	4.46	1.85	0.24	0.15	0.01	7.41
Medtronic Plc	25.17	25.17	2.19	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	33.96	33.96	4.86	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.63	62.63	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.04	51.04	2.23	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.56	16.56	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iradimed Corp	Buy	$897.1M	234.02%	43.81	26.61%
Medtronic Plc	Buy	$116.7B	-9.62%	25.17	13.63%
Edwards Lifesciences Corp.	Buy	$47.6B	1.75%	33.96	72.96%
Boston Scientific Corp.	Buy	$155.9B	167.79%	62.63	13.55%
Stryker Corporation	Buy	$147.1B	107.9%	51.04	12.25%
Abbott Laboratories	Buy	$229.7B	29.36%	16.56	32.43%

About Iradimed Corp

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Organization	Iradimed
Employees	160
CEO	Mr. Roger E. Susi
Industry	Health Technology

Key Management of Iradimed Corp

Name	Title
Mr. Roger E. Susi	Founder, Chairman, CEO & President
Mr. John F. Glenn	CFO & Corporate Secretary
Mr. Jeff Chiprin	Chief Commercial Officer
Mr. Randy Waddell	Vice President of Worldwide Sales & Marketing
Mr. Chris Williamson	Executive Vice President of Continuous Improvement & Information Technology
Mr. Matt Garner	Controller
Mr. Lynn Neuhardt	Vice President of Research & Development

Important FAQs about investing in IRMD Stock from India :

What is Iradimed share price today?

Iradimed share price today is $72.66 as on August 23, 2025 at 1:29 AM IST at the close of the market. Iradimed share today touched a day high of $72.96 and a low of $72.41.

What is the 52 week high and 52 week low for Iradimed share?

Iradimed share touched a 52 week high of $73.47 and a 52 week low of $44.58. Iradimed stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $72.66, lower by 1.1% versus the 52 week high.

How to invest in Iradimed Stock (IRMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Iradimed on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iradimed Shares that will get you 0.0206 shares as per Iradimed share price of $72.66 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Iradimed Stock (IRMD) from India?

Indian investors can start investing in Iradimed (IRMD) shares with as little as ₹87.521 or $1 (as of August 24, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Iradimed stock (as per the Rupee-Dollar exchange rate as on August 24, 2025). Based on Iradimed share’s latest price of $72.66 as on August 23, 2025 at 1:29 AM IST, you will get 0.1376 shares of Iradimed. Learn more about fractional shares .

What are the returns that Iradimed has given to Indian investors in the last 5 years?

Iradimed stock has given 234.02% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?